Drug Patents owned by Apil

1. List of Actonel drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7718634 APIL Method of treatment using bisphosphonic acid
May, 2023

(3 months from now)

US7192938 APIL Method of treatment using bisphosphonic acid
May, 2023

(3 months from now)

US7718634

(Pediatric)

APIL Method of treatment using bisphosphonic acid
Nov, 2023

(9 months from now)

US7192938

(Pediatric)

APIL Method of treatment using bisphosphonic acid
Nov, 2023

(9 months from now)

Drugs and Companies using RISEDRONATE SODIUM ingredient

Market Authorisation Date: 27 March, 1998

Treatment: Treatment of osteoporosis in postmenopausal women; Prevention and treatment of osteoporosis

Dosage: TABLET;ORAL

How can I launch a generic of ACTONEL before it's patent expiration?
More Information on Dosage

2. List of Atelvia drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8246989 APIL Dosage forms of bisphosphonates
Jan, 2026

(2 years from now)

US7645459 APIL Dosage forms of bisphosphonates
Jan, 2028

(4 years from now)

US7645460 APIL Dosage forms of risedronate
Jan, 2028

(4 years from now)

Drugs and Companies using RISEDRONATE SODIUM ingredient

Market Authorisation Date: 08 October, 2010

Treatment: Treatment of osteoporosis in postmenopausal women

Dosage: TABLET, DELAYED RELEASE;ORAL

How can I launch a generic of ATELVIA before it's patent expiration?
More Information on Dosage

3. List of Femtrace drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7572779 APIL Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
Oct, 2025

(2 years from now)

Drugs and Companies using ESTRADIOL ACETATE ingredient

Market Authorisation Date: 20 August, 2004

Treatment: Treatment of moderate to severe vasomotor symptoms associated with menopause

Dosage: TABLET;ORAL

More Information on Dosage

4. List of Lo Loestrin Fe drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7704984 APIL Extended estrogen dosing contraceptive regimen
Feb, 2029

(6 years from now)

Drugs and Companies using ETHINYL ESTRADIOL; NORETHINDRONE ACETATE ingredient

Market Authorisation Date: 21 October, 2010

Treatment: Lo loestrin fe is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception

Dosage: TABLET;ORAL

How can I launch a generic of LO LOESTRIN FE before it's patent expiration?
More Information on Dosage

5. List of Lo Minastrin Fe drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7704984 APIL Extended estrogen dosing contraceptive regimen
Feb, 2029

(6 years from now)

Drugs and Companies using ETHINYL ESTRADIOL; NORETHINDRONE ACETATE ingredient

Market Authorisation Date: 24 July, 2013

Treatment: Prevention of pregnancy

Dosage: TABLET, CHEWABLE, TABLET;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in